Living with Chagas heart disease can be incredibly difficult as the condition progresses to end-stage heart failure. For these patients, a heart transplant is a feasible treatment option. The data shows that these patients can achieve relatively favorable long term survival when compared to other types of heart muscle diseases.
Researchers looked at 305 transplant recipients to see how different factors influenced outcomes. They found that patients who took the medication mycophenolate mofetil showed lower rates of death. They also found that patients who took azathioprine had lower rates of parasite reactivation. However, the study noted that being male was associated with higher rates of complications, reactivation, and death.
It is important to note that these findings come from a historical comparison. Because of factors like different monitoring styles over time and the era of transplantation, the results cannot be used to prove that one medication directly caused the better outcomes. These findings highlight that while transplant is a viable option, individual results depend on many complex factors.
